GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nemaura Medical Inc (OTCPK:NMRD) » Definitions » EBIT per Share

Nemaura Medical (Nemaura Medical) EBIT per Share : $-0.18 (TTM As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Nemaura Medical EBIT per Share?

Nemaura Medical's EBIT per Share for the three months ended in Dec. 2023 was $-0.01. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.18.

During the past 3 years, the average EBIT per Share Growth Rate was -14.60% per year. During the past 5 years, the average EBIT per Share Growth Rate was -17.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Nemaura Medical's EBIT per Share or its related term are showing as below:

NMRD' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -48.1   Med: -24.4   Max: -9.5
Current: -14.6

During the past 10 years, the highest 3-Year average EBIT per Share Growth Rate of Nemaura Medical was -9.50% per year. The lowest was -48.10% per year. And the median was -24.40% per year.

NMRD's 3-Year EBIT Growth Rate is ranked worse than
74.73% of 728 companies
in the Medical Devices & Instruments industry
Industry Median: 6.2 vs NMRD: -14.60

Nemaura Medical's EBIT for the three months ended in Dec. 2023 was $-0.24 Mil.


Nemaura Medical EBIT per Share Historical Data

The historical data trend for Nemaura Medical's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nemaura Medical EBIT per Share Chart

Nemaura Medical Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EBIT per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.25 -0.23 -0.21 -0.32 -0.31

Nemaura Medical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.03 -0.09 -0.07 -0.01 -0.01

Nemaura Medical EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Nemaura Medical's EBIT per Share for the fiscal year that ended in Mar. 2023 is calculated as

EBIT per Share(A: Mar. 2023 )
=EBIT/Shares Outstanding (Diluted Average)
=-7.731/24.878
=-0.31

Nemaura Medical's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

EBIT per Share(Q: Dec. 2023 )
=EBIT/Shares Outstanding (Diluted Average)
=-0.236/28.899
=-0.01

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nemaura Medical  (OTCPK:NMRD) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.


Nemaura Medical EBIT per Share Related Terms

Thank you for viewing the detailed overview of Nemaura Medical's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Nemaura Medical (Nemaura Medical) Business Description

Traded in Other Exchanges
N/A
Address
57 West 57th Street, New York, NY, USA, 10019
Nemaura Medical Inc is a medical technology company developing sugarBEAT as a non-invasive, affordable, and flexible Continuous Glucose Monitor (CGM) designed for people with diabetes and pre-diabetics to manage their glucose levels. Insulin users can adjunctively use sugarBEAT when calibrated with a finger-stick glucose reading. SugarBEAT consists of a daily disposable adhesive skin patch connected to a rechargeable transmitter with an app displaying glucose readings at five-minute intervals for periods up to 24 hours.
Executives
Bashir Timol director, 10 percent owner, officer: Chief Business Officer C/O ONE E GROUP LIMITED, UNIT 3A, SPRINGFIELD COURT, SUMMERFIELD ROAD, BOLTON X0 BL32NT
Chowdhury Dewan Fazlul Hoque director, 10 percent owner, officer: CEO & President CHAMWOOD BUILDING, HOLYWELL PARK, ASHBURY ROAD, LOUGHBOROUGH LEICS X0 LE113AQ
Salim Natha director LOUGHBOROUGHUNIVERSITYSCIENCE&ENTERPRISE, PARKS, 5 OAKWOOD DRIVE, LOUGHBOROUGH, LEICESTERSHIRE X0 LE113QF
Justin James Mclarney officer: Chief Financial Officer C/O NEMAURA MEDICAL INC., 57 WEST 57TH STREET, MANHATTAN NY 10019
Sufyan Ismail 10 percent owner C/O ONE E GROUP LIMITED, UNIT 3A, SPRINGFIELD COURT, SUMMERFIELD ROAD, BOLTON X0 BL32NT
Thomas Peter Moore director C/O NEMAURA MEDICAL, INC., 57 WEST 57TH STREET, MANHATTAN NY 10019
Timothy Christopher Johnson director C/O NEMAURA MEDICAL INC., 57 WEST 57TH STREET, MANHATTAN NY 10019
Iain Anderson officer: CFO LOUGHBOROUGHUNIVERSITYSCIENCE&ENTERPRISE, PARKS, 5 OAKWOOD DRIVE, LOUGHBOROUGH, LEICESTERSHIRE X0 LE113QF
Kathryn Farrar officer: Director of Finance C/O ONE E GROUP LIMITED, UNIT 3A, SPRINGFIELD COURT, SUMMERFIELD ROAD, BOLTON X0 BL32NT
Julie Pomeroy officer: Director of Finance C/O ONE E GROUP LIMITED, UNIT 3A, SPRINGFIELD COURT, SUMMERFIELD ROAD, BOLTON X0 BL32NT
Richard Toon officer: Technical & Bus. Dev. Manager C/O ONE E GROUP LIMITED, UNIT 3A, SPRINGFIELD COURT, SUMMERFIELD ROAD, BOLTON X0 BL32NT

Nemaura Medical (Nemaura Medical) Headlines

From GuruFocus

Nemaura Medical to Present at the Sidoti & Co. Micro Cap Virtual Conference

By Stock market mentor Stock market mentor 01-11-2023

Nemaura Medical to Present at the Planet MIcroCap Showcase: Virtual 2022

By Value_Insider Value_Insider 12-01-2022

Nemaura Medical to Participate in Fireside Chat Hosted by EF Hutton

By sperokesalga sperokesalga 03-21-2023

Nemaura Medical Receives First Purchase Order from U.S. Health Provider HealthFleet

By Stock market mentor Stock market mentor 01-26-2023